Disease associated variation - GWASdb |
Chr | Pos | SNP ID(dbSNP 142) | Ref | Alt | Ori SNP ID | P-value | Drug Name | Drug Anno | GWAS Trait | HPO ID | DO ID | AA | Type | Trait or Drug |
5 | 15586293 | rs7706439 | G | A | rs7706439 | 6.13E-04 | ALDOSTERONE | BIOLOGICAL MARKERS|NATRIURETIC PEPTIDE, BRAIN|RENIN | Blood pressure, CVD RF and other traits (body mass index (BMI), waist:hip ratio, renin activity in plasma, aldosterone concentration in plasma, BNP levels in plasma, alcohol consumption) | HPOID:0011025 | DOID:10763 | G | intron | GWASdb_drug |
5 | 15586293 | rs7706439 | G | A | rs7706439 | 7.79E-04 | ALDOSTERONE | BIOLOGICAL MARKERS|NATRIURETIC PEPTIDE, BRAIN|RENIN | Blood pressure, CVD RF and other traits (body mass index (BMI), waist:hip ratio, renin activity in plasma, aldosterone concentration in plasma, BNP levels in plasma, alcohol consumption) | HPOID:0011025 | DOID:10763 | G | intron | GWASdb_drug |
5 | 15651836 | rs6897885 | T | C | rs6897885 | 5.41E-04 | GEMCITABINE|CYTARABINE | MANNOSYLTRANSFERASES|PIGB PROTEIN, HUMAN|RNA, SMALL INTERFERING|DEOXYCYTIDINE | Response to cytadine analogues (cytosine arabinoside) | HPOID:0002664 | DOID:162 | T | intron | GWASdb_drug |
5 | 15723346 | rs11748700 | A | G | rs11748700 | 2.37E-05 | CALCIUM|CYCLIC AMP | TUMOR SUPPRESSOR PROTEIN P53|ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL | Acute urticaria and angioedema (non-steroidal anti-inflammatory drug-induced) | HPOID:0001025|HPOID:0100665 | DOID:1558 | A | intron | GWASdb_drug |
5 | 15735014 | rs4289558 | A | G | rs4289558 | 5.05E-05 | CALCIUM|CYCLIC AMP | TUMOR SUPPRESSOR PROTEIN P53|ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL | Acute urticaria and angioedema (non-steroidal anti-inflammatory drug-induced) | HPOID:0001025|HPOID:0100665 | DOID:1558 | A | intron | GWASdb_drug |
5 | 15937910 | rs6554906 | T | C | rs6554906 | 1.50E-05 | PRAVASTATIN|CHOLESTEROL|ATORVASTATIN|SIMVASTATIN | PYRROLES|LIPIDS|HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS|HEPTANOIC ACIDS | Response to statin therapy | HPOID:0001677 | DOID:3393|DOID:423|DOID:1936 | C | UTR-3 | GWASdb_drug |
5 | 15938553 | rs3810847 | A | G | rs3810847 | 2.10E-05 | PRAVASTATIN|CHOLESTEROL|ATORVASTATIN|SIMVASTATIN | PYRROLES|LIPIDS|HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS|HEPTANOIC ACIDS | Response to statin therapy | HPOID:0001677 | DOID:3393|DOID:423|DOID:1936 | C | UTR-3 | GWASdb_drug |
5 | 15582005 | rs1978633 | T | G | rs1978633 | 5.00E-06 | | | Economic and political preferences (feminism/equality) | HPOID:0000118 | NA | G | intron | GWASdb_trait |
5 | 15586293 | rs7706439 | G | A | rs7706439 | 6.13E-04 | | | Blood pressure, CVD RF and other traits (body mass index (BMI), waist:hip ratio, renin activity in plasma, aldosterone concentration in plasma, BNP levels in plasma, alcohol consumption) | HPOID:0011025 | DOID:10763 | G | intron | GWASdb_trait |
5 | 15586293 | rs7706439 | G | A | rs7706439 | 7.79E-04 | | | Blood pressure, CVD RF and other traits (body mass index (BMI), waist:hip ratio, renin activity in plasma, aldosterone concentration in plasma, BNP levels in plasma, alcohol consumption) | HPOID:0011025 | DOID:10763 | G | intron | GWASdb_trait |
5 | 15604978 | rs4510586 | C | T | rs4510586 | 3.54E-04 | | | Lung function (forced expiratory flow between 25% and 75% of forced vital capacity) | HPOID:0002088 | DOID:850 | C | intron | GWASdb_trait |
5 | 15618181 | rs12659622 | G | A | rs12659622 | 9.00E-07 | | | Obesity-related traits | HPOID:0001513 | DOID:9970 | G | intron | GWASdb_trait |
5 | 15633019 | rs12652729 | A | G | rs12652729 | 4.05E-04 | | | Type 2 diabetes | HPOID:0005978 | DOID:9352 | A | intron | GWASdb_trait |
5 | 15651836 | rs6897885 | T | C | rs6897885 | 5.41E-04 | | | Response to cytadine analogues (cytosine arabinoside) | HPOID:0002664 | DOID:162 | T | intron | GWASdb_trait |
5 | 15688927 | rs17602097 | G | A | rs17602097 | 3.75E-04 | | | Type 2 diabetes | HPOID:0005978 | DOID:9352 | G,A | intron | GWASdb_trait |
5 | 15697062 | rs4701641 | G | A | rs4701641 | 1.90E-05 | | | Urinary metabolites | HPOID:0000079 | DOID:557 | A | intron | GWASdb_trait |
5 | 15723346 | rs11748700 | A | G | rs11748700 | 2.37E-05 | | | Acute urticaria and angioedema (non-steroidal anti-inflammatory drug-induced) | HPOID:0001025|HPOID:0100665 | DOID:1558 | A | intron | GWASdb_trait |
5 | 15735014 | rs4289558 | A | G | rs4289558 | 5.05E-05 | | | Acute urticaria and angioedema (non-steroidal anti-inflammatory drug-induced) | HPOID:0001025|HPOID:0100665 | DOID:1558 | A | intron | GWASdb_trait |
5 | 15735956 | rs4146556 | A | G | rs4146556 | 8.20E-04 | | | Heart Failure | HPOID:0001635 | DOID:6000 | C | intron | GWASdb_trait |
5 | 15747814 | rs2937075 | A | G | rs2937075 | 7.34E-04 | | | Heart Failure | HPOID:0001635 | DOID:6000 | A | intron | GWASdb_trait |
5 | 15752604 | rs2937076 | T | G | rs2937076 | 3.21E-04 | | | Heart Failure | HPOID:0001635 | DOID:6000 | T | intron | GWASdb_trait |
5 | 15783596 | rs10044254 | A | G | rs10044254 | 9.00E-08 | | | Asthma (corticosteroid response) | HPOID:0002099 | DOID:2841 | A | intron | GWASdb_trait |
5 | 15785038 | rs13183703 | C | T | rs13183703 | 8.57E-05 | | | Height | HPOID:0000002 | NA | C | intron | GWASdb_trait |
5 | 15832573 | rs13158449 | G | T | rs13158449 | 4.22E-05 | | | Diabetes Mellitus | HPOID:0000819 | DOID:9351 | T | intron | GWASdb_trait |
5 | 15937910 | rs6554906 | T | C | rs6554906 | 1.50E-05 | | | Response to statin therapy | HPOID:0001677 | DOID:3393|DOID:423|DOID:1936 | C | UTR-3 | GWASdb_trait |
5 | 15938553 | rs3810847 | A | G | rs3810847 | 2.10E-05 | | | Response to statin therapy | HPOID:0001677 | DOID:3393|DOID:423|DOID:1936 | C | UTR-3 | GWASdb_trait |